- Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. Kernan, N.A., Byers, V., Scannon, P.J., Mischak, R.P., Brochstein, J., Flomenberg, N., Dupont, B., O'Reilly, R.J. JAMA (1988)